Evidence map›Paper›PMID 40108197›Full record

Articlenpj aging2025

Author Correction: The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy.

Yuichi Ikegami, Ikuo Inoue, Kaiji Inoue, Yuichi Shinoda, Shinichiro Iida, Seiichi Goto, Takanari Nakano, Akira Shimada, Mitsuhiko Noda

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in npj aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yuichi IkegamiDepartment of Endocrinology and Diabetology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan. u5i4r21@saitama-med.ac.jp.
Ikuo InoueDepartment of Endocrinology and Diabetology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Kaiji InoueDepartment of Radiology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Yuichi ShinodaDepartment of Rehabilitation, Ibaraki Rehabilitation Hospital, 360 moriya-shi, Ibaraki, 302-0112, Japan.
Shinichiro IidaDepartment of Endocrinology and Diabetology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Seiichi GotoHealth Management Center, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Takanari NakanoDepartment of Biochemistry, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Akira ShimadaDepartment of Endocrinology and Diabetology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.
Mitsuhiko NodaDepartment of Endocrinology and Diabetology, Saitama Medical University, 38 Moroyama, Iruma-gun, Saitama, 350-0495, Japan.ORCID http://orcid.org/0000-0003-0413-4631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40108197
PMCPMC11923195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.